ADEOYE Y OLUKOTUN
CIK 1242615 · Chief Medical Officer · last filed 2026-05-14
ADEOYE Y OLUKOTUN is a Chief Medical Officer who has filed 45 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for TNXP, was dated May 14, 2026. Across all open-market trades the lifetime net is −$1.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.50M
6
45
-$1.70M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TNXP | Director | 0 | $11.35 | $0 | $5.0K | 11 | 2026-05-14 |
| ARWR | Director | 33,600 | $74.52 | $2.50M | -$1.71M | 12 | 2025-12-23 |
| BIOCLINICA INC (BIOC) Delisted | Director | 0 | $0.43 | $0 | $0 | 3 | 2013-03-14 |
| ICAGEN INC (ICGN) Delisted | Director | 0 | — | — | $0 | 11 | 2011-10-28 |
| BIOCLINICA INC (UWBK) Delisted | Director | — | — | — | $0 | 3 | 2010-05-13 |
| VIA Pharmaceuticals, Inc. (VIAP) Delisted | Chief Medical Officer | 59,624 | — | — | $0 | 3 | 2007-12-19 |
Recent Filings
45 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-14 | TNXP | Grant (A) | — | $0 | EDGAR |
| 2025-12-23 | ARWR | Sell (S) | −10,000 | -$676.6K | EDGAR |
| 2025-12-18 | ARWR | Grant (A) | +7,819 | $0 | EDGAR |
| 2025-05-15 | TNXP | Grant (A) | — | $0 | EDGAR |
| 2025-02-28 | TNXP | Other (J) | −0 | -$2 | EDGAR |
| 2025-01-27 | ARWR | Sell (S) | −959 | -$20.1K | EDGAR |
| 2024-12-30 | ARWR | Sell (S) | −2,850 | -$57.0K | EDGAR |
| 2024-12-20 | ARWR | Grant (A) | +16,733 | $384.7K | EDGAR |
| 2024-05-24 | TNXP | Grant (A) | — | $0 | EDGAR |
| 2023-12-19 | ARWR | Grant (A) | +14,987 | $380.8K | EDGAR |